GPX4 and diabetes mellitus: The therapeutic potential of targeting mediators implicated in ferroptosis and pyroptosis per se in DM should be also considered: targeting ferroptosis-specific mediators may pave the way for novel therapeutic approaches in DM, e.g. through the selective activation of GPX4 which could further enhance the benefit preliminary observed with therapy based on GLP-1RAs (63).